Presbyterian Heart Group

Albuquerque, New Mexico 87106-4921

2 studies enrolling now · 19 studies all time

What they study most

Acute Myocardial Infarction, Cardiovascular Disease, Coronary Artery Disease, Heart Failure, Heart Failure With Left Bundle Branch Block, Myocardial Infarction, Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Pulmonary Arterial Hypertension, Sudden Death, Tachyarrhythmia, Tachycardia

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
• Baroreflex Activation Therapy for Heart Failure — Completed
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
• Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
• Optisure Lead Post Approval Study — Stopped early
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• AdaptResponse Clinical Trial — Completed
• Model 4396 Left Ventricular (LV) Lead Chronic Performance Study — Completed
• MultiPoint Pacing™ Post Market Study — Completed
• Personalized CRT - MPP Post Approval Study — Completed
• Vest Prevention of Early Sudden Death Trial and VEST Registry — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• Examining Heart Attacks in Young Women — Completed
• SILVER-AMI: Outcomes in Older Persons With Heart Attacks — Completed
• Quadripolar Pacing Post Approval Study — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• Tyvaso Dosing and Titration Evaluation: TyTRATE Registry — Completed